Back
Novo Nordisk AS Stock Predictions
Sponsored
NVO
Sponsored
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Sell
35
NVO
Novo Nordisk AS
Last Price:
107.20
Seasonality Move:
7.98%
7 Day Trial
ALL ACCESS PASS
$
7
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE TradeNovo Nordisk AS Stock Forecast
- Over the next 52 weeks, Novo Nordisk AS has on average historically risen by 20.1% based on the past 43 years of stock performance.
- Novo Nordisk AS has risen higher in 34 of those 43 years over the subsequent 52-week period, corresponding to a historical accuracy of 79.07%
-
Is Novo Nordisk AS Stock Undervalued?
The current Novo Nordisk AS [NVO] share price is $107.20. The Score for NVO is 35, which is 30% below its historic median score of 50, and infers higher risk than normal. - NVO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Novo Nordisk AS Stock Go Up Next Year?
- Over the next 52 weeks, Novo Nordisk AS has on average historically risen by 20.1% based on the past 43 years of stock performance.
Novo Nordisk AS Stock Rating
Sell
35
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS overpriced?
- Novo Nordisk AS has risen higher in 34 of those 43 years over the subsequent 52-week period, corresponding to a historical accuracy of 79.07%
Novo Nordisk AS Stock Price History
Stock Information
Stock Info
Exchange:
NYSE
Country:
Denmark
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
novonordisk.com
52-Week Data
52-Week High:
148.15
52-Week Low:
94.73
Prediction Charts
Market Cap:
477.02B
Price in USD:
107.20
Volume:
4.96M
Beta:
0.49
Technical Analysis
SMA50:
121.80
SMA100:
128.85
SMA200:
128.26
52-Wk Change:
5.35%
Stock Predictions
-
Is Novo Nordisk AS stock public?
Yes, Novo Nordisk AS is a publicly traded company. -
What is the Novo Nordisk AS stock quote today?
The Novo Nordisk AS stock price is 107.20 USD today. -
How to buy Novo Nordisk AS stock online?
You can buy Novo Nordisk AS shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Oct-22 | 115.00 | 116.47 | 116.65 | 114.76 |
Oct-23 | 116.33 | 115.74 | 116.44 | 114.95 |
Oct-24 | 115.21 | 113.92 | 115.26 | 113.91 |
Oct-25 | 113.90 | 113.38 | 114.19 | 113.10 |
Oct-28 | 112.41 | 112.36 | 112.72 | 111.67 |
Oct-29 | 111.62 | 111.98 | 113.27 | 111.15 |
Oct-30 | 108.89 | 113.24 | 113.76 | 107.24 |
Oct-31 | 110.21 | 111.95 | 112.16 | 109.63 |
Nov-1 | 112.88 | 111.94 | 113.02 | 111.79 |
Nov-4 | 110.19 | 109.72 | 110.66 | 109.44 |
Nov-5 | 107.98 | 110.13 | 110.30 | 107.75 |
Nov-6 | 108.27 | 105.36 | 108.75 | 105.03 |
Nov-7 | 106.10 | 107.63 | 107.74 | 105.59 |
Nov-8 | 107.15 | 107.20 | 107.87 | 106.43 |
Novo Nordisk AS Earnings
Novo Nordisk AS Earnings Report: Per Share Novo Nordisk AS Earnings Q1 Q2 Q3 and Q4 last year and next year.
Novo Nordisk AS Forecast Revenue Growth
Novo Nordisk AS Stock Analysis: Historical quarterly revenues per share for Novo Nordisk AS and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.56 per share, and an increase next year of $0.72 per share.
* Novo Nordisk AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.